Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 23,009 | 18,819 | 22,988 | 26,829 | 22,693 |
| Operating Income | -23,009 | -18,819 | -22,988 | -26,829 | -22,693 |
| Other Income | 1,283 | 1,051 | 1,160 | 1,664 | 691 |
| Pre-tax Income | -21,726 | -17,768 | -21,828 | -25,165 | -22,002 |
| Net Income Continuous | -21,726 | -17,768 | -21,828 | -25,165 | -22,002 |
| Net Income | $-21,726 | $-17,768 | $-21,828 | $-25,165 | $-22,002 |
| EPS Basic Total Ops | -0.72 | -0.59 | -0.72 | -0.84 | -0.73 |
| EPS Basic Continuous Ops | -0.72 | -0.59 | -0.72 | -0.84 | -0.73 |
| EPS Diluted Total Ops | -0.72 | -0.59 | -0.72 | -0.84 | -0.73 |
| EPS Diluted Continuous Ops | -0.72 | -0.59 | -0.72 | -0.84 | -0.73 |
| EPS Diluted Before Non-Recurring Items | -0.72 | -0.59 | -0.72 | N/A | N/A |
| EBITDA(a) | $-23,009 | $-18,819 | $-22,988 | $-26,829 | $-22,693 |